Moderna Inc. (NASDAQ: MRNA) is one of the high short interest stocks to buy right now. On November 20, Moderna announced that ...

The U.S. is in "big danger" of falling behind in vaccine technology research as government funding declines and vaccine ...

Although the COVID pandemic led to a better understanding of the coronaviruses, viruses, and vaccines, a backlash emerged to ...

Researchers at the Department of Cell and Molecular Biology, Karolinska Institutet have captured the first detailed molecular snapshots of human polynucleotide phosphorylase (hPNPase) in action, ...

No matter where cancer cells grow in the human body, they are a threat to our health and our lives. But instead of treating ...

Moderna ​reiterated its previous statement that there were no new or undisclosed safety concerns in children or in pregnant ...

Stanford Medicine investigators have unearthed the biological process by which mRNA-based vaccines for COVID-19 can cause heart damage in some young men and adolescents - and they've shown a possible ...

No matter where cancer cells grow in the human body, they are a threat to our health and our lives. But instead of treating ...

Study points to source of "very, very rare" cases of myocarditis and potential solutions. Myocarditis risk remains far higher ...

A rapid, two-step immune reaction may underlie rare cases of heart inflammation seen after Covid mRNA vaccination, Stanford ...

Nanomedicine in 2026 will emphasize safe scale-up and mechanistically aware therapies, bridging the gap between research and ...

MOSCOW, December 9. /TASS/. The first three test series of the mRNA anti-cancer vaccine have been manufactured in Russia, Alexander Gintsburg, Director of the Gamaleya National Research Center for ...